Regular low-calorie sweetener consumption is associated with increased secretion of glucose-dependent insulinotropic polypeptide

Chee W. Chia, Michelle Shardell, Kristofer S. Gravenstein, Olga D. Carlson, Eleanor Marie Simonsick, Luigi Ferrucci, Josephine M. Egan

Research output: Contribution to journalArticle


Low-calorie sweeteners (LCSs) are widely used for weight control despite limited evidence of their effectiveness and studies linking LCS consumption with incident obesity. We tested the hypothesis that regular LCS consumption is associated with higher postprandial glucose-dependent insulinotropic polypeptide (GIP) secretion, which has been linked to obesity. We used data from participants in the Baltimore Longitudinal Study of Aging who had completed a diet diary, had at least one visit during which they underwent an oral glucose tolerance test (OGTT), and had no diabetes. Of 232 participants, 166 contributed 1, 39 contributed 2, and 27 contributed 3 visits, and 96 (41%) reported using LCS. Plasma OGTT samples were analysed for glucose, insulin and GIP. Fasting glucose, insulin and GIP levels were no different between LCS users and non-users. The association of LCS use with 2-hour OGTT responses after adjustment for covariates was non-significant for glucose (P=.98) and insulin (P=.18), but significant for greater increase in GIP in LCS users (P=.037). Regular consumption of LCSs was associated with greater increases in GIP secretion after food intake, which may potentially lead to weight gain through the lipogenic properties of GIP.

Original languageEnglish (US)
JournalDiabetes, Obesity and Metabolism
StateAccepted/In press - Jan 1 2018
Externally publishedYes



  • GIP
  • Incretins
  • Observational study

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this